InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2034”
The global digital pathology market is estimated to reach over USD 3,981.2 million by 2034, exhibiting a CAGR of 13.1% during the forecast period.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1629
The increasing incidence of cancer, the rising adoption of digital pathology in pharmaceutical research, and the growing integration of digital pathology solutions to enhance laboratory efficiency are among the primary factors driving market expansion. Additionally, the rising prevalence of cardiovascular diseases serves as a key catalyst for the development of advanced diagnostic technologies, further boosting the demand for digital pathology systems throughout the forecast period.
Technological advancements—such as automation, robotic-assisted light microscopy, and advanced fiber optic communications—are also expected to significantly contribute to the wider adoption of digital pathology solutions in the coming years.
List of Prominent Players in the Digital Pathology Market:
- Biosystems (US)
- Koninklijke Philips N.V. (Netherlands)
- Hamamatsu Photonics (Japan)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- 3DHISTECH (Hungary)
- Apollo Enterprise Imaging (US)
- XIFIN, Inc. (US)
- Huron Digital Pathology (Canada)
- Visiopharm A/S (Denmark)
- Aiforia Technologies Oy (Finland)
- Akoya Biosciences (US)
- Corista (US)
- Indica Labs (US)
- Objective Pathology Services (Canada)
- Sectra AB (Sweden)
- OptraSCAN (US)
- Glencoe Software (US)
- KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China)
- Inspirata, Inc. (US)
- PathAI (US)
- Proscia Inc. (US)
- Kanteron Systems (Spain)
- Mikroscan Technologies (US)
- Motic (US)
- Paige (US)
Market Dynamics:
Drivers-
The increasing effectiveness of digital pathology in research applications is significantly contributing to rising demand, particularly from the oncology research sector. This growing demand is also attracting government investments aimed at enhancing clinical diagnostic capabilities through digital pathology solutions.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1629
Challenges:
Despite the promising outlook, several factors are likely to hinder market expansion during the forecast period. These include stringent regulatory requirements governing primary diagnoses and the absence of standardized guidelines across regions. Furthermore, the high cost of digital pathology systems, combined with a shortage of skilled professionals capable of operating these advanced technologies, may restrict widespread implementation.
Regional Trends:
North America is projected to maintain a leading position in the digital pathology market, supported by an established infrastructure and strong demand within the healthcare and pharmaceutical sectors. The region’s growth is primarily driven by increasing cancer prevalence, expanded use in pharmaceutical research, and rising adoption to enhance laboratory efficiency. Europe also holds a significant share of the market, with increased consumer preference for digital solutions and the growing implementation of technologically advanced products contributing to the region’s market expansion.
Recent Developments:
- In March 2022-Ion Torrent Genexus Dx Integrated Sequencer, an automated next-generation sequencing (NGS) platform for use in clinical laboratories and to conduct diagnostic and clinical research, was introduced by Thermo Fisher Scientific, Inc. with the CE-IVD marking.
- In April 2022-A contract between the Catalan Health Institute and 3DHISTECH Ltd. was signed. This plan was implemented to introduce digital pathology tools across an eight-hospital network.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1629
Segmentation of Digital Pathology Market-
By Product
- Scanners
- Brightfield
- Other Scanners
- Software
- Integrated Software
- Standalone Software
- Information Management Software
- Image Analysis Software
- Storage Systems
By Type
- Human Pathology
- Veterinary Pathology
By Application
- Drug Discovery
- Disease Diagnosis
- Training & Education
By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals and Reference Laboratories
- Academic & Research Institutes
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Get More Information:@
https://www.insightaceanalytic.com/report/digital-pathology-market/1629
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
